New PET scan rules could better predict cancer outcomes
NCT ID NCT06448208
First seen Mar 16, 2026 · Last updated May 13, 2026 · Updated 8 times
Summary
This study is testing new guidelines for reading PET scans in people with neuroendocrine tumors. The goal is to see if these new criteria can more accurately predict whether a person's cancer improves, worsens, or stays the same after treatment. About 11 participants who are already scheduled for a standard treatment called PRRT will have their scans analyzed using both the new and current methods.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROENDOCRINE TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
Conditions
Explore the condition pages connected to this study.